Skip to main content

AstraZeneca antibody therapy prevents COVID-19 in trial, company says

AstraZeneca released Phase 3 data showing promising results for a combination antibody therapy that prevents COVID-19, possibly opening the door to an alternative option for people who may not see the full protective benefits from the currently authorized vaccines.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.